These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 24172895)

  • 1. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
    Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
    Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice.
    Iwabu M; Okada-Iwabu M; Tanabe H; Ohuchi N; Miyata K; Kobori T; Odawara S; Kadowaki Y; Yokoyama S; Yamauchi T; Kadowaki T
    Commun Biol; 2021 Jan; 4(1):45. PubMed ID: 33420419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic features of AdipoAI, a novel AdipoR agonist.
    Ahuja A; Zboinski E; das S; Zhu X; Ma Q; Xie Y; Tu Q; Chen J
    Cell Biochem Funct; 2024 Jan; 42(1):e3910. PubMed ID: 38269524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.
    Kim Y; Lim JH; Kim EN; Hong YA; Park HJ; Chung S; Choi BS; Kim YS; Park JY; Kim HW; Park CW
    Cell Death Dis; 2022 Mar; 13(3):282. PubMed ID: 35351872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
    Zatorski H; Salaga M; Zielińska M; Majchrzak K; Binienda A; Kordek R; Małecka-Panas E; Fichna J
    Molecules; 2021 May; 26(10):. PubMed ID: 34063466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.
    Kim Y; Park CW
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
    Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
    J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis.
    Xu H; Zhao Q; Song N; Yan Z; Lin R; Wu S; Jiang L; Hong S; Xie J; Zhou H; Wang R; Jiang X
    Nat Commun; 2020 Nov; 11(1):5807. PubMed ID: 33199780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
    Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
    J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.
    Ito R; Higa M; Goto A; Aoshima M; Ikuta A; Ohashi K; Yokoyama S; Ohno Y; Egawa T; Miyata H; Goto K
    PLoS One; 2018; 13(10):e0205645. PubMed ID: 30308063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice.
    Wang Y; Wan Y; Ye G; Wang P; Xue X; Wu G; Ye B
    Eur J Pharm Sci; 2016 Oct; 93():123-31. PubMed ID: 27516150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice.
    Hong J; Jia Y; Pan S; Jia L; Li H; Han Z; Cai D; Zhao R
    Oncotarget; 2016 Aug; 7(35):56071-56082. PubMed ID: 27528227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity.
    Okada-Iwabu M; Iwabu M; Yamauchi T; Kadowaki T
    Diabetol Int; 2019 Oct; 10(4):237-244. PubMed ID: 31592400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway.
    Yu J; Zheng J; Lu J; Sun Z; Wang Z; Zhang J
    Neurochem Res; 2019 Jul; 44(7):1678-1689. PubMed ID: 30982205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.